Oak Review

Oak's verdict: one flat price, no dose-creep penalty — and it just got cheaper

Oak (run by Oak Longevity Holdings Corp.) is built around a single idea most GLP-1 telehealth services don't honor: you pay one price no matter what dose you're on. For semaglutide that's $119 a month, every month, from starter dose to full titration — and that headline rate actually dropped at our latest re-check, not rose. But it's compounded-only, the pharmacy isn't named, and the fine print is unusually strict, so it isn't for everyone.

How the flat, all-dose pricing actually works

Most compounding telehealth pricing is tiered: the milligrams go up, and so does your monthly charge. Oak collapses that into a flat rate. Compounded semaglutide is $119 per month across all dose strengths, and compounded tirzepatide is $185 flat — both cheaper than at our spring verification. The homepage sums up the model in three words — one price, all dosages, no subscriptions — and an FAQ even promises price-matching. The old first-month promo code is gone; Oak now advertises a new-patient discount and a seasonal sale banner, but neither publishes its terms or the resulting price, so treat those offers as unconfirmed until checkout.

Why this matters: GLP-1 dosing escalates over your first several months, so on a tiered plan the maintenance dose where the medication works best is also the most expensive. On Oak, your month-three bill looks exactly like your month-one bill. Against a category median of $169, the semaglutide rate is well below average — and it stays there. One wrinkle from our re-verification: Oak's own site is internally inconsistent, with older, higher figures lingering in metadata and on a couple of subpages. We anchor on the hero pricing, which matched our first-hand signup walk — but it's sloppy housekeeping for a company selling on price.

• Free shipping is included, not an add-on at checkout.
• Free health coaching comes standard with the medication.
• No video call is required — it's an asynchronous intake form.
• Pricing is shown before intake, so you know the number before handing over health information.

What Oak prescribes and how it reaches you

Oak offers exactly two medications: compounded semaglutide and compounded tirzepatide, both injectable. There is no oral version and no brand-name option — you will not get Wegovy, Ozempic, Zepbound, or Mounjaro here. Prescriptions are issued through NVP Medical Group, P.A. You fill out the online health form, check out, and a licensed provider reviews your information — approval can come within hours, after which Oak's partner pharmacies fill the prescription and ship it free.

The real differentiator — and its honest catch

Oak's genuine edge is the no-markup-as-you-titrate model bundled with free shipping and coaching; for a long-term GLP-1 user, predictable pricing is the whole game, and few competitors guarantee it. The standout catch is transparency: Oak still refers only to 'licensed U.S. compounding pharmacies' without naming them anywhere on the public site. For a medication you inject, not knowing which pharmacy fills it is a real disclosure gap.

What customers say

This is a genuine improvement since our earlier reviews, when Oak had essentially no external review footprint. Its claimed Trustpilot profile now shows a 4.6 out of 5 'Excellent' rating from 53 reviews, and the company has replied to 100% of its negative reviews — a small but real signal someone is minding the store. The counterweight: there's still no BBB listing and no Google business profile we could locate, so those 53 reviews are the entire independent record. Encouraging, but thin.

Who should pick Oak — and who should walk

Oak is a good fit if you want compounded semaglutide or tirzepatide at the lowest stable price you can find, you're comfortable with an injection, and you'd rather skip a live video consult. The flat rate rewards people who plan to stay on therapy long-term and climb to a maintenance dose.

Skip Oak if you specifically want brand-name medication (it offers none), if you need an oral pill instead of an injection, or if naming your pharmacy upfront is a dealbreaker. Also weigh the fine print: there is no money-back guarantee, fees are non-refundable per the Terms of Use, and disputes go to binding arbitration under Delaware law.

Trust, safety, and medical oversight

On the reassuring side: Oak carries a LegitScript certification, prescriptions run through a licensed medical group, and our check of the FDA warning-letter database turned up no actions against Oak Longevity Holdings Corp. On the cautious side, we rate verification confidence as medium: the pharmacy partners aren't publicly named, the claimed 45-state coverage list is gated behind the signup intake, and the medication is compounded rather than FDA-approved brand product. None of these are red flags alone; together they're why Oak's trust score stays capped despite the improving value story. See our scoring methodology for how we weigh these factors.

Bottom line

Oak does one thing unusually well: it removes the dose-creep penalty that makes other compounded GLP-1 plans get pricier exactly when they start working. At $119 a month flat for semaglutide and $185 flat for tirzepatide — against a $169 category median, with free shipping and coaching thrown in — the value is genuine, and the new Trustpilot record adds a first layer of outside evidence. Just go in clear-eyed: it's compounded and injectable only, the pharmacy isn't named, the advertised discounts don't publish their terms, and the no-refund, arbitration-only terms are stricter than most. If those tradeoffs are acceptable, Oak is one of the best flat-rate deals in the category.

Worth pricing against PeterMD ($105/month) and Try Ageless ($119/month) before you commit — both sit close to Oak on cost and formulation.